Search Results 661-670 of 17909 for monoclonal antibody

1. Tumor Size is Defining Factor to Response from Promising Melanoma Drug - Mayo Clinic News Network

   The likely reason for this finding is that MK-3475 is a monoclonal antibody that stimulates the body's immune system response to the tumors, Dr. Joseph says ...

2. Find a cancer clinical trial - Mayo Clinic Research

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

3. Epidemiology of Monoclonal B-Cell Lymphocytosis Study - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

   The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic is studying connections between monoclonal B-cell lymphocytosis and blood and lymph node ...

4. Nivolumab and hyaluronidase-nvhy (subcutaneous route) - Side effects & uses - Mayo Clinic

   Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or ...

5. Mayo Clinic Q & A - Dr. Petersen and Dr. Knopman - YouTube A...

   So, Aducanumab is a monoclonal antibody that is designed to be infused into the bloodstream, get into the brain, and remove amyloid plaques from the brain ...

6. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...

7. Viral hemorrhagic fevers - Diagnosis and treatment - Mayo Clinic

   And the Food and Drug Administration has approved monoclonal antibody therapies Inmazeb and Ebanga to treat Ebola. Therapy. Supportive care may help you feel ...

8. Mild cognitive impairment - Diagnosis and treatment - Mayo Clinic

   Known as monoclonal antibodies, they include: Lecanemab-irmb (Leqembi). This medicine is given as an IV infusion every two weeks. It can cause infusion ...

9. Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers - Mayo Clinic

   Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...

10. Mayo Clinic Q and A: Ways patients who are immunocompromised can protect themselves from COVID-19

    ... monoclonal antibody therapy called sotrovimab, as well as an oral antiviral drug called Paxlovid and an IV antiviral drug called remdesivir. These drugs are ...